Withdrawal with transdermal fentanyl.
Higgs
C M
CM
Vella-Brincat
J
J
D000279:Administration, Cutaneous; D005283:Fentanyl / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000009:adverse effects* / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology
D009020:Morphine; D005283:Fentanyl